CMPX logo

Compass Therapeutics (CMPX) Net Income

Annual Net Income

-$42.49 M
-$3.27 M-8.33%

31 December 2023

CMPX Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$10.48 M
+$2.60 M+19.85%

01 September 2024

CMPX Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$47.76 M
-$517.00 K-1.09%

01 September 2024

CMPX TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CMPX Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.3%-5.2%-17.4%
3 y3 years-44.0%-75.4%+38.5%
5 y5 years-11.0%-22.6%-175.1%

CMPX Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-44.0%+48.3%-75.4%+21.9%-38.0%+41.9%
5 y5 years-44.0%+48.3%-88.6%+81.2%-175.1%+41.9%
alltimeall time-44.0%+48.3%-88.6%+81.2%-442.2%+41.9%

Compass Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$10.48 M(-19.8%)
-$47.76 M(+1.1%)
June 2024
-
-$13.08 M(+21.2%)
-$47.24 M(+4.0%)
Mar 2024
-
-$10.79 M(-19.6%)
-$45.44 M(+6.9%)
Dec 2023
-$42.49 M(+8.3%)
-$13.41 M(+34.6%)
-$42.49 M(+4.5%)
Sept 2023
-
-$9.96 M(-11.7%)
-$40.67 M(-4.7%)
June 2023
-
-$11.28 M(+43.9%)
-$42.68 M(+7.0%)
Mar 2023
-
-$7.84 M(-32.4%)
-$39.90 M(+1.7%)
Dec 2022
-$39.23 M(-52.3%)
-$11.59 M(-3.2%)
-$39.23 M(-3.4%)
Sept 2022
-
-$11.97 M(+41.0%)
-$40.61 M(+17.3%)
June 2022
-
-$8.49 M(+18.6%)
-$34.61 M(-57.8%)
Mar 2022
-
-$7.16 M(-44.8%)
-$81.92 M(-0.3%)
Dec 2021
-$82.18 M
-
-
DateAnnualQuarterlyTTM
Dec 2021
-
-$12.98 M(+117.3%)
-$82.18 M(+5.9%)
Sept 2021
-
-$5.97 M(-89.3%)
-$77.59 M(-3.9%)
June 2021
-
-$55.80 M(+651.9%)
-$80.77 M(+164.6%)
Mar 2021
-
-$7.42 M(-11.5%)
-$30.52 M(+3.5%)
Dec 2020
-$29.50 M(-15.1%)
-$8.39 M(-8.3%)
-$29.50 M(+6.4%)
Sept 2020
-
-$9.15 M(+64.7%)
-$27.72 M(+2.2%)
June 2020
-
-$5.56 M(-13.2%)
-$27.12 M(-10.7%)
Mar 2020
-
-$6.40 M(-3.2%)
-$30.38 M(+26.7%)
Dec 2019
-$34.74 M(-9.3%)
-$6.61 M(-22.7%)
-$23.97 M(+38.1%)
Sept 2019
-
-$8.55 M(-2.9%)
-$17.36 M(+97.1%)
June 2019
-
-$8.81 M
-$8.81 M
Dec 2018
-$38.29 M
-
-

FAQ

  • What is Compass Therapeutics annual net profit?
  • What is the all time high annual net income for Compass Therapeutics?
  • What is Compass Therapeutics annual net income year-on-year change?
  • What is Compass Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Compass Therapeutics?
  • What is Compass Therapeutics quarterly net income year-on-year change?
  • What is Compass Therapeutics TTM net profit?
  • What is the all time high TTM net income for Compass Therapeutics?
  • What is Compass Therapeutics TTM net income year-on-year change?

What is Compass Therapeutics annual net profit?

The current annual net income of CMPX is -$42.49 M

What is the all time high annual net income for Compass Therapeutics?

Compass Therapeutics all-time high annual net profit is -$29.50 M

What is Compass Therapeutics annual net income year-on-year change?

Over the past year, CMPX annual net profit has changed by -$3.27 M (-8.33%)

What is Compass Therapeutics quarterly net profit?

The current quarterly net income of CMPX is -$10.48 M

What is the all time high quarterly net income for Compass Therapeutics?

Compass Therapeutics all-time high quarterly net profit is -$5.56 M

What is Compass Therapeutics quarterly net income year-on-year change?

Over the past year, CMPX quarterly net profit has changed by -$517.00 K (-5.19%)

What is Compass Therapeutics TTM net profit?

The current TTM net income of CMPX is -$47.76 M

What is the all time high TTM net income for Compass Therapeutics?

Compass Therapeutics all-time high TTM net profit is -$8.81 M

What is Compass Therapeutics TTM net income year-on-year change?

Over the past year, CMPX TTM net profit has changed by -$7.09 M (-17.42%)